IP Library › Granted Patent US 9,896,658
Granted Patent B2
US 9,896,658 · App. 14/833,919 · Granted Feb 20, 2018

Generation of inner ear auditory hair cell

Inventor: Albert Edge (Brookline, MA)
Assignee: Massachusetts Eye & Eat Infirmary
C12N5/0627C12N5/062C12N2501/42C12N2506/1353
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,896,658
App. No.
14/833,919
Granted
Feb 20, 2018
Kind
B2
Abstract

Methods for generating cells of the inner ear, e.g., hair cells and supporting cells, from stem cells, e.g., mesenchymal stem cells, are provided, as well as compositions including the inner ear cells. Methods for the therapeutic use of the inner ear cells for the treatment of hearing loss are also described.

Claims (8)

1. An in vitro method of generating a differentiated inner ear auditory hair cell, the method comprising:

(i) providing a population of mesenchymal stem cells obtained from mammalian bone marrow;

(ii) culturing the mesenchymal stem cell in serum-free medium containing insulin-like growth factor-1 (IGF-1), epidermal growth factor (EGF), and basic fibroblast growth factor (bFGF);

(iii) inducing the stem cell by maintaining said cell in medium comprising neurotrophin-3 (NT-3) and brain derived neurotrophic factor (BDNF) for time sufficient to differentiate into a progenitor cell that expresses Sox2, Pax6, nestin, and musashih; and

(iv) culturing the progenitor cell in the presence of a gamma secretase inhibitor in an amount and for a time sufficient to produce a differentiated inner ear auditory hair cell that expresses myosin VIIa, and espin and optionally expresses one or both of atonal homolog 1 (Atoh1) or jagged 2,

thereby producing a differentiated inner ear auditory hair cell, wherein the gamma secretase inhibitor is selected from the group consisting of an arylsulfonamide, a dibenzazepine, a benzodiazepine, N—[N-(3,5-difluorophenacetyl)-L-alanyl]-(S)-phenylglycine t-butyl ester (DAPT), L-685,458, and MK0752.

2. The method of claim 1 , wherein the mesenchymal stem cell is obtained from a subject who has sensorineural hair cell loss.

3. The method of claim 1 , wherein the inner ear auditory hair cell expresses Atoh1, myosin7a, and epsin.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 17, 2016
From: EDGE, ALBERT
To: MASSACHUSETTS EYE & EAR INFIRMARY
Reel/Frame 037748/0740 →
Continuity (5)
Continuation 13759441 · Feb 5, 2013
Continuation 12233017 · Sep 18, 2008
Continuation PCTUS2007084654 · Nov 14, 2007
Provisional Application 60859041 · Nov 15, 2006
Related Publication 20160046906A1 · Feb 18, 2016